PERSEGHIN GIANLUCA

Pugliese, N., Spertino, M., Mercurio, M., Ciardullo, S., Perseghin, G., Hassan, C., et al. (2026). Effect of Weight Loss on Clinical Outcomes in Patients With Chronic Gastrointestinal and Liver Diseases. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 24(3), 583-594 [10.1016/j.cgh.2025.10.018]. Detail

Candido, R., Buzzetti, R., Consoli, A., Irace, C., Torre, E., Trevisan, R., et al. (2026). Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensus. ACTA DIABETOLOGICA, 63(2), 313-323 [10.1007/s00592-025-02619-8]. Detail

Vergani, M., Borella, N., Rizzo, M., Conti, M., Perra, S., Bianconi, E., et al. (2025). Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional study. DIABETES, OBESITY AND METABOLISM, 27(6), 3201-3211 [10.1111/dom.16333]. Detail

Rea, F., Muraca, E., Morabito, G., Oltolini, A., Bongo, A., Perseghin, G., et al. (2025). Medication Use Before and After Different Bariatric Surgery Procedures: Results from a Population-Based Cohort Study. OBESITY SURGERY, 35(6), 2240-2248 [10.1007/s11695-025-07911-8]. Detail

Mantovani, A., Ciardullo, S., Sani, E., Csermely, A., Shtembari, E., Milani, I., et al. (2025). Association between continuous glucose monitoring metrics and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes undergoing vibration-controlled transient elastography: a multicenter cross-sectional study. DIABETES & METABOLISM, 51(5 (September 2025)) [10.1016/j.diabet.2025.101684]. Detail